Dispensing Endorsement Guidance

Dispensing endorsements are required under certain circumstances to ensure that the appropriate reimbursement and remuneration is received by contractors. The dispenser should provide clear and unambiguous information on the designated section of the prescription form against which the PPD can calculate payments.

The use of unnecessary dispensing endorsements is a common problem and can be avoided through an understanding of the circumstances in which they are actually required. The PPD and the Pharmaceutical Services Negotiating Committee (PSNC) have produced the following guidance for pharmacists to refer to when making dispensing endorsements:

Alphabetical Guide to Prescription Endorsement - Quick Reference Guide

For specific guidance relating to the endorsement of FP10MDA prescription forms the following guidance has been issued by the PPD:

FP10MDA Dispensing Endorsement Guidance

Endorsement guidance was issued to dispensing doctor practices on 10 March 2006 to reflect changes to the Statement of Financial Entitlements:

Dispensing Endorsement Guidance for Dispensing Doctor Practices

The NHSBSA Prescription Pricing Division have published guidance on the endorsement of electronic prescriptions for Release 2 of the Electronic Prescription Service (EPS2). This guidance, intended for suppliers of EPS2 compliant software systems, is reproduced here.

Branded drugs that are produced by more than one manufacturer on the dispensing endorsement guidance

Guidance issued by the PPD in order to allow accurate reimbursement of branded products which are licenced under the same name but are available from more than one manufacturer.